Immune Response Mechanisms in Aquatic Vaccination

Aquatic vaccination harnesses the innate and adaptive immune systems of fish and other cultured species to prevent infectious disease in intensive farming environments. Antigens delivered by immersion, oral or injection routes are first encountered by mucosal surfaces—skin, gills and gut—where specialised antigen-presenting cells sample and process vaccine components. Innate defences, including complement activation, lysozyme secretion and pattern recognition receptor signalling, provide immediate barriers and shape the ensuing adaptive response. B-cell populations, predominantly secreting IgM and IgT (a mucosal immunoglobulin), differentiate in lymphoid organs such as the spleen and head kidney, while T-cell subsets drive helper and cytotoxic functions. Adjuvants and delivery systems, including nanoparticles and mucoadhesive formulations, are used to enhance antigen uptake, sustain release and bias cellular versus humoral immunity. Understanding the coordination between local mucosal reactions and systemic protection is essential for designing vaccines that are both practical for mass administration and effective in reducing mortality, improving animal welfare and supporting sustainable aquaculture worldwide.

Research from Nature Portfolio

A foundational study evaluated alternatives to traditional mineral oil adjuvants in an intraperitoneal vaccine against Aeromonas salmonicida in rainbow trout, comparing CpG oligodeoxynucleotides, a liposomal cationic adjuvant (CAF01) and Freund’s incomplete adjuvant. Both the nucleotide- and liposome-based formulations markedly reduced macroscopic and microscopic adverse effects at the injection site while maintaining a level of protective efficacy equivalent to the oil benchmark. Distinct immunological signatures were observed: CpG formulations induced a sustained T_H1-like transcriptional profile, whereas the liposomal adjuvant demonstrated transient antibody elevation paired with signs of enhanced cell-mediated immunity. These insights into adjuvant-driven modulation of safety and response kinetics offer a pathway for developing safer and more targeted fish vaccines.

Immune Response Mechanisms in Aquatic Vaccination publication trend

The graph below shows the total number of articles in immune response mechanisms in aquatic vaccination across all publications each year (not limited to Nature Index journals).

Technical terms

Mucosal immunity: Immune defences associated with mucous-lined surfaces, including specialised antibodies (IgT/IgZ) and antigen-presenting cells.

Adjuvant: A substance co-administered with an antigen to enhance and direct the immune response, for example by stimulating innate receptors or prolonging antigen release.

IgM: The predominant systemic immunoglobulin in fish, responsible for primary antigen neutralisation and complement activation.

Nanoparticle vaccine: A delivery system utilising nanoscale carriers (often polymeric or liposomal) to protect antigens, facilitate mucosal uptake and control release kinetics.

MHC class II: Major histocompatibility complex proteins expressed on antigen-presenting cells that present exogenous peptide fragments to CD4⁺ T cells.

References

1. Study on Immune Response of Organs of Epinephelus coioides and Carassius auratus After Immersion Vaccination With Inactivated Vibrio harveyi Vaccine. Frontiers in Immunology (2021).
2. Alternatives to mineral oil adjuvants in vaccines against Aeromonas salmonicida subsp. salmonicida in rainbow trout offer reductions in adverse effects. Scientific Reports (2017).
3. Immersion Vaccination by a Biomimetic-Mucoadhesive Nanovaccine Induces Humoral Immune Response of Red Tilapia (Oreochromis sp.) against Flavobacterium columnare Challenge. Vaccines (2021).
4. Development of Immersion and Oral Bivalent Nanovaccines for Streptococcosis and Columnaris Disease Prevention in Fry and Fingerling Asian Seabass (Lates calcarifer) Nursery Farms. Vaccines (2023).